Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,043 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Use of historical control data for assessing treatment effects in clinical trials.
Viele K, Berry S, Neuenschwander B, Amzal B, Chen F, Enas N, Hobbs B, Ibrahim JG, Kinnersley N, Lindborg S, Micallef S, Roychoudhury S, Thompson L. Viele K, et al. Among authors: thompson l. Pharm Stat. 2014 Jan-Feb;13(1):41-54. doi: 10.1002/pst.1589. Epub 2013 Aug 5. Pharm Stat. 2014. PMID: 23913901 Free PMC article. Review.
Bayesian methods for design and analysis of safety trials.
Price KL, Xia HA, Lakshminarayanan M, Madigan D, Manner D, Scott J, Stamey JD, Thompson L. Price KL, et al. Among authors: thompson l. Pharm Stat. 2014 Jan-Feb;13(1):13-24. doi: 10.1002/pst.1586. Epub 2013 Jul 30. Pharm Stat. 2014. PMID: 23897858
Factors Determining Black Carbon Exposures among Pregnant Women Enrolled in the HAPIN Trial.
Campbell DA, Johnson M, Piedrahita R, Pillarisetti A, Waller LA, Kearns KA, Kremer J, Mollinedo E, Sarnat JA, Clark ML, Underhill LJ, McCracken JP, Diaz-Artiga A, Steenland K, Rosa G, Kirby MA, Balakrishnan K, Sambandam S, Mukhopadhyay K, Sendhil S, Natarajan A, Ndagijimana F, Dusabimana E, Thompson LM, Checkley W, Nicolaou L, Hartinger S, Peel JL, Clasen TF, Naeher LP. Campbell DA, et al. Among authors: thompson lm. Environ Sci Technol. 2024 May 29. doi: 10.1021/acs.est.3c09991. Online ahead of print. Environ Sci Technol. 2024. PMID: 38810212
Bedaquiline-pretomanid-moxifloxacin-pyrazinamide for drug-sensitive and drug-resistant pulmonary tuberculosis treatment: a phase 2c, open-label, multicentre, partially randomised controlled trial.
Cevik M, Thompson LC, Upton C, Rolla VC, Malahleha M, Mmbaga B, Ngubane N, Abu Bakar Z, Rassool M, Variava E, Dawson R, Staples S, Lalloo U, Louw C, Conradie F, Eristavi M, Samoilova A, Skornyakov SN, Ntinginya NE, Haraka F, Praygod G, Mayanja-Kizza H, Caoili J, Balanag V, Dalcolmo MP, McHugh T, Hunt R, Solanki P, Bateson A, Crook AM, Fabiane S, Timm J, Sun E, Spigelman M, Sloan DJ, Gillespie SH; SimpliciTB Consortium. Cevik M, et al. Among authors: thompson lc. Lancet Infect Dis. 2024 May 17:S1473-3099(24)00223-8. doi: 10.1016/S1473-3099(24)00223-8. Online ahead of print. Lancet Infect Dis. 2024. PMID: 38768617 Free article.
4,043 results